[artículo] 
inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 5 (Octubre) . - pp. 479-483

Título :	Hyperprolactinemia in patients on antipsychotic drugs causes adp-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study
Tipo de documento:	texto impreso
Autores:	Henri Wallaschofski, Autor ; Martin Eigenthaler, Autor ; Markus Kiefer, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 479-483
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Hiperprolactinemia, Activación plaquetaria, Tromboembolismo.
Resumen:	Recently, an increased risk of venous thromboembolism in patients on antipsychotic drugs has been reported, but the molecular etiology is still unknown. Most antipsychotic drugs act as dopamine antagonists, and some of them cause hyperprolactinemia. Hyperprolactinemia has recently been found to cause increased platelet activation via potentiating ADP effects on human platelets.
Link:	./index.php?lvl=notice_display&id=31002

[artículo] Hyperprolactinemia in patients on antipsychotic drugs causes adp-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study [texto impreso] / Henri Wallaschofski, Autor ; Martin Eigenthaler, Autor ; Markus Kiefer, Autor . - 2023 . - pp. 479-483.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 5 (Octubre) . - pp. 479-483

Palabras clave:	Antipsicóticos, Hiperprolactinemia, Activación plaquetaria, Tromboembolismo.
Resumen:	Recently, an increased risk of venous thromboembolism in patients on antipsychotic drugs has been reported, but the molecular etiology is still unknown. Most antipsychotic drugs act as dopamine antagonists, and some of them cause hyperprolactinemia. Hyperprolactinemia has recently been found to cause increased platelet activation via potentiating ADP effects on human platelets.
Link:	./index.php?lvl=notice_display&id=31002